(Q45856180)

17 December 2017

title

Melanoma cultures show different susceptibility towards E1A-, E1B-19 kDa- and fiber-modified replication-competent adenoviruses (English)

1 reference

17 December 2017

1 reference

Schmitz M

1 reference

17 December 2017

Graf C

1 reference

17 December 2017

Gut T

1 reference

17 December 2017

Sirena D

1 reference

17 December 2017

Peter I

1 reference

17 December 2017

Dummer R

1 reference

17 December 2017

Greber UF

1 reference

17 December 2017

Hemmi S

1 reference

17 December 2017

publication date

1 June 2006

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

1 reference

17 December 2017

issue

1 reference

17 December 2017

page(s)

893-905

1 reference

17 December 2017

Efficient gene transfer by fiber-mutant adenoviral vectors containing RGD peptide

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302739

Enhanced Adenovirus Infection of Melanoma Cells by Fiber-Modification: Incorporation of RGD Peptide or Ad5/3 Chimerism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302739

Replication-selective virotherapy for cancer: Biological principles, risk management and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302739

7 January 2021

A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302739

7 January 2021

Adenoviral vectors with E1A regulated by tumor-specific promoters are selectively cytolytic for breast cancer and melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302739

7 January 2021

A novel attenuated replication-competent adenovirus for melanoma therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302739

7 January 2021

Conditionally replication-competent adenoviral vectors with enhanced infectivity for use in gene therapy of melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302739

7 January 2021

Replication-selective oncolytic viruses in the treatment of cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302739

7 January 2021

Efficacy of a replication-competent adenovirus (ONYX-015) following intratumoral injection: intratumoral spread and distribution effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302739

7 January 2021

A blood-tumor barrier limits gene transfer to experimental liver cancer: the effect of vasoactive compounds.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302739

7 January 2021

Wild-type adenovirus decreases tumor xenograft growth, but despite viral persistence complete tumor responses are rarely achieved--deletion of the viral E1b-19-kD gene increases the viral oncolytic effect

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302739

7 January 2021

Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302739

7 January 2021

Deletion of the adenoviral E1b-19kD gene enhances tumor cell killing of a replicating adenoviral vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302739

7 January 2021

Evaluation of E1B gene-attenuated replicating adenoviruses for cancer gene therapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302739

7 January 2021

An E1B-19 kDa gene deletion mutant adenovirus demonstrates tumor necrosis factor-enhanced cancer selectivity and enhanced oncolytic potency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302739

7 January 2021

Melanoma genetics: an update with focus on the CDKN2A(p16)/ARF tumor suppressors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302739

7 January 2021

A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302739

7 January 2021

An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302739

7 January 2021

Tumor-specific, replication-competent adenovirus vectors overexpressing the adenovirus death protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302739

7 January 2021

Evaluation of E1-mutant adenoviruses as conditionally replicating agents for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302739

7 January 2021

Targeted adenovirus vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302739

7 January 2021

An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302739

7 January 2021

Selective transduction of murine myelomonocytic leukemia cells (WEHI-3B) with regular and RGD-adenoviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302739

7 January 2021

Effective gene transfer to human melanomas via integrin-targeted adenoviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302739

7 January 2021

The alphavbeta5 integrin of hematopoietic and nonhematopoietic cells is a transduction receptor of RGD-4C fiber-modified adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302739

7 January 2021

Combining high selectivity of replication with fiber chimerism for effective adenoviral oncolysis of CAR-negative melanoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302739

7 January 2021

Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302739

7 January 2021

Improved adenovirus vectors for infection of cardiovascular tissues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302739

7 January 2021

Exploiting the natural diversity in adenovirus tropism for therapy and prevention of disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302739

7 January 2021

Adenovirus type 11 uses CD46 as a cellular receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302739

7 January 2021

CD46 is a cellular receptor for group B adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302739

7 January 2021

The human membrane cofactor CD46 is a receptor for species B adenovirus serotype 3

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302739

7 January 2021

Deletion of the gene encoding the adenovirus 5 early region 1b 21,000-molecular-weight polypeptide leads to degradation of viral and host cell DNA

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302739

7 January 2021

The distal short consensus repeats 1 and 2 of the membrane cofactor protein CD46 and their distance from the cell membrane determine productive entry of species B adenovirus serotype 35

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302739

7 January 2021

The presence of human coxsackievirus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302739

7 January 2021

Adenovirus serotype 3 utilizes CD80 (B7.1) and CD86 (B7.2) as cellular attachment receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302739

7 January 2021

Adenovirus E1B 19K protein is required for efficient DNA replication in U937 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302739

7 January 2021

Inhibition of ICE-like proteases inhibits apoptosis and increases virus production during adenovirus infection.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302739

7 January 2021

The E3-11.6-kDa adenovirus death protein (ADP) is required for efficient cell death: characterization of cells infected with adp mutants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302739

7 January 2021

Late expression of p53 from a replicating adenovirus improves tumor cell killing and is more tumor cell specific than expression of the adenoviral death protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302739

7 January 2021

Gene transfer to ovarian cancer versus normal tissues with fiber-modified adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302739

7 January 2021

Dendritic cells transduced with gp100 gene by RGD fiber-mutant adenovirus vectors are highly efficacious in generating anti-B16BL6 melanoma immunity in mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302739

7 January 2021

Comparison of the efficiency of transduction of leukemic cells by fiber-modified adenoviruses.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302739

7 January 2021

Adenovirus-activated PKA and p38/MAPK pathways boost microtubule-mediated nuclear targeting of virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302739

7 January 2021

Signalling in viral entry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302739

7 January 2021

The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302739

7 January 2021

A monoclonal antibody detecting the adenovirus type 5-E1b-58Kd tumor antigen: characterization of the E1b-58Kd tumor antigen in adenovirus-infected and -transformed cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302739

7 January 2021

Monoclonal antibodies specific for adenovirus early region 1A proteins: extensive heterogeneity in early region 1A products

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302739

7 January 2021

Functional and selective targeting of adenovirus to high-affinity Fcgamma receptor I-positive cells by using a bispecific hybrid adapter

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302739

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302739

1 reference

17 December 2017

Dimensions Publication ID

1031000793

0 references

1 reference

17 December 2017